Metabolic dysfunction-associated fatty liver disease (MAFLD) affects approximately 25% of the global population and is typically linked to obesity. Notably, emerging evidence indicates that 12%–20% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results